Public- and private-sector partnerships in contraceptive research and development: guiding principles

International Journal of Gynecology and Obstetrics

Volumn 67, Issue SUPPL. 2, 1999, Pages

  Brooke, S ^a   Vail, J G ^a  

^a PATH   (United States)

Author keywords

Contraceptive research and development; Licensing agreements; Preferential pricing; Public private sector collaboration; Royalties

Indexed keywords

CONTRACEPTIVE AGENT;

CONFERENCE PAPER; CONTRACEPTION; COOPERATION; COST; DEVELOPING COUNTRY; ETHICS; HUMAN; LICENSING; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; PROSPECTIVE PRICING; RESEARCH;

EID: 0032729824     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(99)00156-3     Document Type: Conference Paper

References (7)

1. Rockefeller Foundation. Public/private sector collaboration in contraceptive research and development: a call for a new partnership (report from a Bellagio conference, 10-14 April 1995). New York: The Rockefeller Foundation. 1995.
2. PATH. Enhancing the private sector's role in contraceptive research and development, 1993.
3. PATH. Market-related issues affecting the participation of the private sector in contraceptive development (report to the Rockefeller Foundation), 1994.
4. Gelijns A.C., Pannenborg C.O. The development of contraceptive technology: case studies of incentives and disincentives to innovation. Int J Technol Assess Health Care. 9(2):1993;210-232.
5. Institute of Medicine, Committee on Contraceptive Research and Development, Division of Health Sciences Policy. The market for new contraceptives: translating unmet need into market demand. In: Harrison PF, Rosenfield A, editors. Contraceptive research and development: looking to the future. Washington, DC: National Academy Press, 1996:166-235.
6. Salkever D., Frank R. Economic issues in vaccine purchase arrangements. Pauly L.M., Robinson C.A., Sepe S.J. Supplying vaccine: an economic analysis of critical issues. 1996;133-152 IOS Press, Washington, DC.
7. Mercer Management Consulting. Summary of UNICEF study: a commercial perspective on vaccine supply. New York: Mercer Management Consulting, 1994.